[Summary] Summary of Consolidated Financial Results for the Three Months Ended August 31, 2026 (Under Japanese GAAP)
Filed with TSE · · 11 pages · English
Daito Pharmaceutical Co., Ltd. on 6ix
In the deck
Story so far
Earlier from Daito Pharmaceutical
- Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical's Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ
- FY2026 4Q Earnings Presentation
- Notice Regarding the Results and Completion of the Acquisition of Treasury Shares Through Off-Auction Own Share Repurchase Transaction (ToSTNet-3)
- Summary of Consolidated Financial Results for the Fiscal Year Ended May 31,2026 (Under Japanese GAAP)
- PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer
Follow Daito Pharmaceutical into a list and get an email when it puts out news.
Follow Daito Pharmaceutical